Mark Hughes Foundation Limited
Concentration RiskGiving Philosophy
The foundation believes that brain cancer research requires game-changing breakthroughs and innovative approaches to improve patient outcomes. MHF invests in seed funding to kickstart potentially transformative research projects, supports the translational pipeline from laboratory to clinical application, and prioritises collaborative projects that bring together researchers across institutions. Their approach aligns with the National Brain Cancer Mission, focusing on funding ideas with the greatest chance of significant impact while also providing direct patient support through care coordinators.
Tips for Applicants
The MHF Scientific Committee prioritises innovative, collaborative projects that align with their core objective of improving brain cancer patient outcomes. Applications should demonstrate clear potential for breakthrough impact rather than incremental research. The committee specifically looks for projects that bring new ideas and people together across research institutes. Given that grants are managed through HMRI's Research Services Team, ensure all documentation meets their administrative requirements. Review previously funded projects on the MHF website to understand the scope and style of funded research.
Programs & Opportunities (3)
The Mark Hughes Foundation Innovation Grants provide vital seed funding for innovative research projects across Australia to improve outcomes for patients diagnosed with brain cancer, with a particular focus on collaborative projects. These grants are open to medical researchers from universities or research institutes across Australia.
Funds are available for innovative research projects that improve outcomes for brain cancer patients, emphasizing collaboration and new ideas.
Two-year research projects focusing on innovative brain cancer treatments, diagnostics, immunotherapy, and patient/family support. Administered through HMRI Research Services with grants of $150,000-$200,000 per project.
Notable Grants
- $2 million Innovation Grant Round (2019) - Multiple research projects across Australia
- $1.5 million Innovation Grant Round (2020) - Up to 10 projects funded
- Funding for Brain Cancer Care Coordinator Nurses (Sandy and Alicia)
- Clinical trials and drug trial support
- Travel grants for researchers to attend COGNO Annual Scientific Meeting
Financial History (6 years)
| Year | Revenue | Expenses | Assets | Surplus |
|---|---|---|---|---|
| 2023 | $6.5M | $5.8M | $10.2M | $676K |
| 2022 | $5.7M | $4.7M | $9.6M | $1.1M |
| 2021 | $5.0M | $2.9M | $8.3M | $2.1M |
| 2020 | $4.9M | $5.1M | $6.2M | $-211,947 |
| 2019 | $8.0M | $5.8M | $6.5M | $2.3M |
| 2018 | $5.1M | $927K | $4.8M | $4.1M |
Community Evidence
External EvidenceIdentity
- GS ID
- AU-ABN-17622847376
- ABN
- 17622847376
- Sector
- health
- Financial Year
- 2023
Focus Areas
Board & Leadership (9)
- Jennifer Hawesdirector
- Kirralee Hughesdirector
- Mark Hughesdirector
- Michael Hartdirector
- Michelle Lawsondirector
- Nicholas Dandirector
- Rolly De Withdirector
- Kirralee Hughesother
- Mark Hughesother
Financials
- Revenue
- $6.5M
- Assets
- $10.2M
Method
- Match Confidence
- registry
- Cross-references
- 2 datasets
- Match Key
- ABN
- Relationships
- 24
Matched by Australian Business Number (ABN) — high confidence. This entity was found across multiple government datasets using the same ABN.
Data Sources
JusticeHub
External LinkThis entity is also tracked in JusticeHub with 0 interventions and 0 evidence records.
External ecosystem profile linked from GrantScope for additional context. JusticeHub content is maintained separately.
View on JusticeHubLocation Intelligence
- Postcode
- 2303
- Locality
- HAMILTON
- Remoteness
- Major Cities of Australia
- SEIFA Disadvantage
- Decile 5/10
- LGA
- Newcastle
- SA2 Region
- Hamilton - Broadmeadow
- Entities in Area
- 139